NO169290C - Analogifremgangsmaate for fremstilling av et terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt - Google Patents
Analogifremgangsmaate for fremstilling av et terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreadduktInfo
- Publication number
- NO169290C NO169290C NO852871A NO852871A NO169290C NO 169290 C NO169290 C NO 169290C NO 852871 A NO852871 A NO 852871A NO 852871 A NO852871 A NO 852871A NO 169290 C NO169290 C NO 169290C
- Authority
- NO
- Norway
- Prior art keywords
- preparing
- amino
- tetrapyrrol
- dicarboxylic acid
- therapeutic active
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000004952 Polyamide Substances 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920002647 polyamide Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
- Rolls And Other Rotary Bodies (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/631,925 US4675338A (en) | 1984-07-18 | 1984-07-18 | Tetrapyrrole therapeutic agents |
Publications (3)
Publication Number | Publication Date |
---|---|
NO852871L NO852871L (no) | 1986-01-20 |
NO169290B NO169290B (no) | 1992-02-24 |
NO169290C true NO169290C (no) | 1992-06-03 |
Family
ID=24533344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO852871A NO169290C (no) | 1984-07-18 | 1985-07-18 | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt |
Country Status (11)
Country | Link |
---|---|
US (1) | US4675338A (ja) |
EP (1) | EP0168832B1 (ja) |
JP (2) | JPH0688902B2 (ja) |
AT (1) | ATE94547T1 (ja) |
AU (1) | AU579387B2 (ja) |
CA (1) | CA1262862C (ja) |
DE (1) | DE3587579T2 (ja) |
DK (1) | DK167768B1 (ja) |
HK (1) | HK135994A (ja) |
NO (1) | NO169290C (ja) |
SG (1) | SG103194G (ja) |
Families Citing this family (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649151A (en) * | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
US4675338A (en) * | 1984-07-18 | 1987-06-23 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
JPS61186385A (ja) * | 1985-02-13 | 1986-08-20 | Sato Yakugaku Kenkyusho:Kk | デユウテロポルフイリン誘導体及びその塩 |
DK168690B1 (da) * | 1985-04-30 | 1994-05-24 | Nippon Petrochemicals Co Ltd | Farmaceutiske præparater til detektion og/eller behandling af pattedyrtumorer |
JPS625986A (ja) * | 1985-04-30 | 1987-01-12 | Nippon Petrochem Co Ltd | 新規なテトラピロ−ル化合物 |
US4656186A (en) * | 1985-04-30 | 1987-04-07 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US5066274A (en) * | 1985-04-30 | 1991-11-19 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole therapeutic agents |
US4977177A (en) * | 1985-04-30 | 1990-12-11 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
AU603999B2 (en) * | 1985-10-23 | 1990-12-06 | Photochemical Co., Ltd. | Porphyrin derivatives, and their production and use |
US5051415A (en) * | 1986-01-02 | 1991-09-24 | The University Of Toledo | Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions |
US5534506A (en) * | 1986-01-02 | 1996-07-09 | University Of Toledo | Use of purpurins, chlorins and purpurin- and chlorin-containing compositions |
US5216012A (en) * | 1986-01-02 | 1993-06-01 | University Of Toledo | Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions |
US4772681A (en) * | 1986-01-17 | 1988-09-20 | Hamari Chemicals, Ltd. | Porphyrin derivatives |
US4877872A (en) * | 1986-06-24 | 1989-10-31 | The University Of Toledo | Production and use of dimers of hematoporophyrin, purpurins, chlorines and purpurin- and chlorin-complexes |
US4920143A (en) * | 1987-04-23 | 1990-04-24 | University Of British Columbia | Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents |
US5283255A (en) * | 1987-01-20 | 1994-02-01 | The University Of British Columbia | Wavelength-specific cytotoxic agents |
US4883790A (en) * | 1987-01-20 | 1989-11-28 | University Of British Columbia | Wavelength-specific cytotoxic agents |
US5095030A (en) * | 1987-01-20 | 1992-03-10 | University Of British Columbia | Wavelength-specific cytotoxic agents |
US5171749A (en) * | 1987-01-20 | 1992-12-15 | University Of British Columbia | Wavelength-specific cytotoxic agents |
JPH0629196B2 (ja) * | 1987-12-01 | 1994-04-20 | 甲子郎 梅村 | 超音波による腫瘍治療用生理作用増強剤 |
US5004811A (en) * | 1987-12-24 | 1991-04-02 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole aminocarboxylic acids |
US5192788A (en) * | 1988-05-23 | 1993-03-09 | Georgia State University Foundation, Inc. | Porphyrin antiviral compositions |
US5109016A (en) * | 1988-05-23 | 1992-04-28 | Georgia State University Foundation, Inc. | Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions |
US4925736A (en) * | 1988-07-06 | 1990-05-15 | Long Island Jewish Medical Center | Topical hematoporphyrin |
DE3827940A1 (de) * | 1988-08-13 | 1990-03-01 | Schering Ag | 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
US4959356A (en) * | 1989-05-26 | 1990-09-25 | The United States Of America As Represented By The United States Department Of Energy | Porphyrins for boron neutron capture therapy |
US4997639A (en) * | 1989-11-27 | 1991-03-05 | Nippon Petrochemicals Company, Limited | Method for detecting cholesterol deposited in bodies of mammals |
US5238940A (en) * | 1990-03-22 | 1993-08-24 | Quadra Logic Technologies Inc. | Compositions for photodynamic therapy |
US5053423A (en) * | 1990-03-22 | 1991-10-01 | Quadra Logic Technologies Inc. | Compositions for photodynamic therapy |
US5219878A (en) * | 1990-10-05 | 1993-06-15 | Queen's University | Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents |
EP0553116A1 (en) * | 1990-10-05 | 1993-08-04 | Queen's University At Kingston | Porphyrin derivatives |
JP3154742B2 (ja) * | 1991-04-30 | 2001-04-09 | 日本石油化学株式会社 | 哺乳類の動脈硬化症治療剤 |
US5330741A (en) * | 1992-02-24 | 1994-07-19 | The Regents Of The University Of California | Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors |
US5658892A (en) * | 1993-01-15 | 1997-08-19 | The General Hospital Corporation | Compound delivery using high-pressure impulse transients |
US5614502A (en) * | 1993-01-15 | 1997-03-25 | The General Hospital Corporation | High-pressure impulse transient drug delivery for the treatment of proliferative diseases |
JP3565442B2 (ja) * | 1993-04-22 | 2004-09-15 | 新日本石油化学株式会社 | 哺乳類の関節炎の診断剤および/または治療剤 |
US5492924A (en) * | 1993-09-24 | 1996-02-20 | Fox Chase Cancer Center | Phorbine derivatives and their use in the diagnosis and therapy of cancer |
US5474910A (en) * | 1993-10-15 | 1995-12-12 | Alfano; Robert R. | Method and device for detecting biological molecules and/or microorganisms within a desired area or space |
US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
WO1995026325A2 (en) * | 1994-03-25 | 1995-10-05 | Isotechnika Inc. | Enhancement of the efficacy of drugs by deuteration |
JP2961074B2 (ja) * | 1995-09-06 | 1999-10-12 | 明治製菓株式会社 | 光化学療法用の新生血管閉塞剤 |
WO1998019677A1 (fr) * | 1996-11-06 | 1998-05-14 | Meiji Seika Kaisha, Ltd. | Traitement de maladies auto-immunes par photochimiotherapie |
US6444194B1 (en) | 1997-02-14 | 2002-09-03 | Miravant Pharmaceuticals, Inc. | Indium photosensitizers for PDT |
CA2298586A1 (en) * | 1997-08-05 | 1999-02-18 | Katsuo Aizawa | Immunity suppression by photochemotherapy |
US6413495B1 (en) * | 1998-07-10 | 2002-07-02 | Meiji Seika Kaisha, Ltd. | X-ray intercepting metal complexes of chlorin derivatives |
CA2356532A1 (en) * | 1999-01-15 | 2000-07-20 | Light Sciences Corporation | Noninvasive vascular therapy |
US6602274B1 (en) * | 1999-01-15 | 2003-08-05 | Light Sciences Corporation | Targeted transcutaneous cancer therapy |
US6454789B1 (en) * | 1999-01-15 | 2002-09-24 | Light Science Corporation | Patient portable device for photodynamic therapy |
US20030114434A1 (en) * | 1999-08-31 | 2003-06-19 | James Chen | Extended duration light activated cancer therapy |
US7166719B2 (en) | 2002-06-27 | 2007-01-23 | Health Research, Inc. | Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy |
US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
US6984655B1 (en) * | 2000-02-17 | 2006-01-10 | Meiji Seika Kaisha, Ltd. | Photodynamic therapy for selectively closing neovasa in eyeground tissue |
WO2002048154A2 (en) * | 2000-12-15 | 2002-06-20 | Mitokor | Cobalt-porphyrin complexes and use thereof as an anti-obesity agent |
US20030167033A1 (en) * | 2002-01-23 | 2003-09-04 | James Chen | Systems and methods for photodynamic therapy |
US7053210B2 (en) | 2002-07-02 | 2006-05-30 | Health Research, Inc. | Efficient synthesis of pyropheophorbide a and its derivatives |
IL152900A0 (en) * | 2002-11-17 | 2003-06-24 | Yeda Res & Dev | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
CN2885311Y (zh) | 2006-01-18 | 2007-04-04 | 郑成福 | 经尿道光动力疗法前列腺治疗仪 |
US20080269846A1 (en) * | 2003-03-14 | 2008-10-30 | Light Sciences Oncology, Inc. | Device for treatment of blood vessels using light |
US10376711B2 (en) * | 2003-03-14 | 2019-08-13 | Light Sciences Oncology Inc. | Light generating guide wire for intravascular use |
US20060141049A1 (en) * | 2003-11-12 | 2006-06-29 | Allergan, Inc. | Triamcinolone compositions for intravitreal administration to treat ocular conditions |
US20070224278A1 (en) * | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
AU2005209201B2 (en) | 2004-01-20 | 2010-06-03 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
WO2005110374A1 (en) * | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
US8425929B2 (en) | 2004-04-30 | 2013-04-23 | Allergan, Inc. | Sustained release intraocular implants and methods for preventing retinal dysfunction |
US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
US8512738B2 (en) | 2004-04-30 | 2013-08-20 | Allergan, Inc. | Biodegradable intravitreal tyrosine kinase implants |
US8591885B2 (en) * | 2004-04-30 | 2013-11-26 | Allergan, Inc. | Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems |
US20050244471A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Estradiol derivative and estratopone containing sustained release intraocular implants and related methods |
US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
US8147865B2 (en) | 2004-04-30 | 2012-04-03 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US8455656B2 (en) | 2004-04-30 | 2013-06-04 | Allergan, Inc. | Kinase inhibitors |
US9498457B2 (en) | 2004-04-30 | 2016-11-22 | Allergan, Inc. | Hypotensive prostamide-containing biodegradable intraocular implants and related implants |
US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
US7771742B2 (en) | 2004-04-30 | 2010-08-10 | Allergan, Inc. | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
US20050244500A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Intravitreal implants in conjuction with photodynamic therapy to improve vision |
US20050244463A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular vasculopathies |
US20050244462A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Devices and methods for treating a mammalian eye |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
US20050244465A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Drug delivery systems and methods for treatment of an eye |
US20050244478A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Anti-excititoxic sustained release intraocular implants and related methods |
US20070059336A1 (en) * | 2004-04-30 | 2007-03-15 | Allergan, Inc. | Anti-angiogenic sustained release intraocular implants and related methods |
US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
US20050244461A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Controlled release drug delivery systems and methods for treatment of an eye |
US8673341B2 (en) * | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
JP2008505978A (ja) * | 2004-07-12 | 2008-02-28 | アラーガン、インコーポレイテッド | 眼病用組成物および眼病治療法 |
WO2006043965A1 (en) * | 2004-10-14 | 2006-04-27 | Allergan, Inc. | Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
US20070142880A1 (en) * | 2005-11-07 | 2007-06-21 | Barnard William L | Light delivery apparatus |
WO2007103427A2 (en) * | 2006-03-06 | 2007-09-13 | Wang Xiang H | Medical use of bilirubin and its structural analogues |
CN100408581C (zh) * | 2006-04-30 | 2008-08-06 | 中国人民解放军总医院 | 3-(1-烷氧基乙基)-8-乙基-2,7,12,15,18-五甲基-13-羧酸-17-丙酸、其合成方法和光动力治疗药物 |
CN100369914C (zh) * | 2006-04-30 | 2008-02-20 | 中国人民解放军总医院 | 3-烯基-8-乙基-2,7,12,15,18-五甲基-13-羧酸-17-丙酸氨基酸酰胺、其合成方法及光动力治疗药物 |
CN101490057B (zh) * | 2006-06-30 | 2013-02-27 | 光子科学肿瘤研究公司 | 制造光活性剂的组合物和方法 |
US8969415B2 (en) | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
FR2914302A1 (fr) * | 2007-03-30 | 2008-10-03 | Sanofi Pasteur Sa | Procede de preparation de derives de porphyrine, telle que la protoporphyrine (ix) et intermediaire de synthese |
US7911053B2 (en) * | 2007-04-19 | 2011-03-22 | Marvell World Trade Ltd. | Semiconductor packaging with internal wiring bus |
US8318794B2 (en) * | 2008-11-25 | 2012-11-27 | Science Group Pty. Ltd. | Method of use of porphyrins in preparing a medicament for sonodynamic therapy and a method of sonodynamic therapy using porphyrins |
KR101769637B1 (ko) | 2009-11-09 | 2017-08-18 | 알러간, 인코포레이티드 | 모발 성장을 촉진하기 위한 조성물 및 방법 |
WO2014071138A1 (en) | 2012-11-02 | 2014-05-08 | Lewis Thomas J | Disease detection and treatment through activation of compounds using external energy |
KR20150119254A (ko) | 2013-02-15 | 2015-10-23 | 알러간, 인코포레이티드 | 지속된 약물 전달 임플란트 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4393071A (en) * | 1975-03-17 | 1983-07-12 | Naoharu Fujii | Method of treating gastric, mammary, lung and uterus tumors |
JPS53112900A (en) * | 1977-03-14 | 1978-10-02 | Ajinomoto Co Inc | Porphyrin derivative |
JPS58201791A (ja) * | 1982-05-19 | 1983-11-24 | Katsuo Unno | ヘマトポルフイリン誘導体 |
ATE53204T1 (de) * | 1982-09-27 | 1990-06-15 | Photofrin Medical Inc | Gereinigte hematoporphyrinabkoemmlinge fuer diagnose und tumorbehandlung sowie verfahren. |
US4649151A (en) * | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
JPS60158687A (ja) * | 1984-01-27 | 1985-08-20 | Matsushita Electric Ind Co Ltd | 半導体レ−ザ |
JPS60158686A (ja) * | 1984-01-27 | 1985-08-20 | Matsushita Electric Ind Co Ltd | 半導体レ−ザ |
US4675338A (en) * | 1984-07-18 | 1987-06-23 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US4693885A (en) * | 1984-07-18 | 1987-09-15 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
-
1984
- 1984-07-18 US US06/631,925 patent/US4675338A/en not_active Expired - Lifetime
-
1985
- 1985-07-18 NO NO852871A patent/NO169290C/no not_active IP Right Cessation
- 1985-07-18 AT AT85108987T patent/ATE94547T1/de not_active IP Right Cessation
- 1985-07-18 JP JP60158686A patent/JPH0688902B2/ja not_active Expired - Lifetime
- 1985-07-18 DE DE85108987T patent/DE3587579T2/de not_active Expired - Lifetime
- 1985-07-18 AU AU45158/85A patent/AU579387B2/en not_active Expired
- 1985-07-18 JP JP60158687A patent/JPH0689000B2/ja not_active Expired - Lifetime
- 1985-07-18 CA CA487040A patent/CA1262862C/en not_active Expired
- 1985-07-18 DK DK326785A patent/DK167768B1/da not_active IP Right Cessation
- 1985-07-18 EP EP85108987A patent/EP0168832B1/en not_active Expired - Lifetime
-
1994
- 1994-07-26 SG SG103194A patent/SG103194G/en unknown
- 1994-12-01 HK HK135994A patent/HK135994A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS6183186A (ja) | 1986-04-26 |
EP0168832A2 (en) | 1986-01-22 |
AU579387B2 (en) | 1988-11-24 |
NO852871L (no) | 1986-01-20 |
HK135994A (en) | 1994-12-09 |
JPS61129163A (ja) | 1986-06-17 |
US4675338A (en) | 1987-06-23 |
DE3587579D1 (de) | 1993-10-21 |
NO169290B (no) | 1992-02-24 |
ATE94547T1 (de) | 1993-10-15 |
EP0168832A3 (en) | 1988-05-04 |
CA1262862A (en) | 1989-11-14 |
JPH0689000B2 (ja) | 1994-11-09 |
EP0168832B1 (en) | 1993-09-15 |
DK326785A (da) | 1986-01-19 |
DK326785D0 (da) | 1985-07-18 |
JPH0688902B2 (ja) | 1994-11-09 |
SG103194G (en) | 1994-10-28 |
DE3587579T2 (de) | 1994-02-17 |
DK167768B1 (da) | 1993-12-13 |
AU4515885A (en) | 1986-03-27 |
CA1262862C (en) | 1989-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO169290C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt | |
NO169293C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt pofyrin-amino-monocarboxylsyreaddukt | |
OA06421A (fr) | Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides. | |
NO852872L (no) | Fremgangsmaate for fremstilling av nye tetrapyrroler. | |
HUT58334A (en) | Process for producing diazines and pharmaceutical compositions containing them as active components | |
HK1039488A1 (en) | Tricylic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases. | |
DE3775882D1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
ATE63124T1 (de) | Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung. | |
HU910930D0 (en) | Process for the production of 2,8-dioxa-bicyclo/3.2.1/octane derivatives and medical preparations containing them | |
DE3570437D1 (en) | 1-hydroxy-1,1-diphosphonic-acid derivatives, process for their preparation and pharmaceutical preparations, especially for the treatment of bone tumours | |
DE3667059D1 (en) | Benzodipyrroles, processes for their preparation and pharmaceutical compositions containing these compounds | |
HU904201D0 (en) | Process for producing peptides with haemoregulating effect and pharmaceutical preparatives containing these compounds | |
IL79910A0 (en) | Tricyclic compounds,process for the preparation thereof and pharmaceutical compositions containing the same | |
ATE267832T1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
EP0061234A3 (en) | Cephalosporin derivatives, process for their preparation and pharmaceutical preparations containing them | |
PT97365A (pt) | Processo de tratamento com compostos de benzodiazepina e de composicoes farmaceuticaas contendo aqueles compostos | |
HUT42493A (en) | Process for producing new conjugates and derivatives of vinblastine and pharmaceutical compositions containing them | |
IT1250653B (it) | Enzimi fibrinolitici ammidati e loro precursori, e processi per la loro preparazione. | |
ES8301233A1 (es) | Un procedimiento para la preparacion de antibioticos de b-lactama. | |
ATE10934T1 (de) | Peptid, verfahren zu dessen herstellung und dessen verwendung. | |
HU905030D0 (en) | Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds | |
AT383811B (de) | Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten | |
KR840002006A (ko) | 포스포르아미드 유도체, 그의 제법 및 그것을 함유하는 의약 | |
RU94035756A (ru) | Производные имидазола, являющиеся ингибиторами питокинов, способы их получения, фармацевтическая композиция |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |